Reports that a Canadian subsidiary of Amgen Inc. will spend C$100 million over the next ten years to create a medical research institute in Toronto that will study the human immune system and how it relates to diseases such as cancer. Amgen Institute; Ontario Cancer Institute/Princess Margaret Hospital (OCI/PMH); Comment from Daniel Billen, general manager of Amgen Canada; Tak Wah Mak, head of the institute; Further details.